1
|
Ivanov I, Krone B, Schulz K, Shaik RB, Parvaz MA, Newcorn JH. Effects of Stimulant Treatment on Changes in Brain Activation During Reward Notifications in Drug Naïve Youth With ADHD. J Atten Disord 2024; 28:847-860. [PMID: 38293912 DOI: 10.1177/10870547231219762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2024]
Abstract
BACKGROUND Research examining the potential effects of stimulant exposure in childhood on subsequent development of substance use disorder (SUD) have focused on differences in the brain reward system as a function of risk. METHODS 18 drug naïve children ages 7 to 12 years (11 High Risk [ADHD + ODD/CD]; 7 Low Risk [ADHD only]), underwent fMRI scans before and after treatment with mixed amphetamine salts, extended release (MAS-XR). We examined correlations between clinical ratings and fMRI activation at baseline and following treatment as a function of risk status. RESULTS High Risk children had higher activation than Low Risk children at baseline during both the Reward and Surprising Non-Reward conditions. Treatment produced strong differential effects on brain activation pertinent to group and reward outcome. CONCLUSIONS Findings support the hypothesized role of reward mechanisms in SUD risk, and suggest that stimulant treatment may have differential effects on reward processing in relation to SUD risk.
Collapse
Affiliation(s)
- Iliyan Ivanov
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Beth Krone
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Kurt Schulz
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Riaz B Shaik
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | | |
Collapse
|
2
|
Bel-Bahar TS, Khan AA, Shaik RB, Parvaz MA. A scoping review of electroencephalographic (EEG) markers for tracking neurophysiological changes and predicting outcomes in substance use disorder treatment. Front Hum Neurosci 2022; 16:995534. [PMID: 36325430 PMCID: PMC9619053 DOI: 10.3389/fnhum.2022.995534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Accepted: 09/20/2022] [Indexed: 11/24/2022] Open
Abstract
Substance use disorders (SUDs) constitute a growing global health crisis, yet many limitations and challenges exist in SUD treatment research, including the lack of objective brain-based markers for tracking treatment outcomes. Electroencephalography (EEG) is a neurophysiological technique for measuring brain activity, and although much is known about EEG activity in acute and chronic substance use, knowledge regarding EEG in relation to abstinence and treatment outcomes is sparse. We performed a scoping review of longitudinal and pre-post treatment EEG studies that explored putative changes in brain function associated with abstinence and/or treatment in individuals with SUD. Following PRISMA guidelines, we identified studies published between January 2000 and March 2022 from online databases. Search keywords included EEG, addictive substances (e.g., alcohol, cocaine, methamphetamine), and treatment related terms (e.g., abstinence, relapse). Selected studies used EEG at least at one time point as a predictor of abstinence or other treatment-related outcomes; or examined pre- vs. post-SUD intervention (brain stimulation, pharmacological, behavioral) EEG effects. Studies were also rated on the risk of bias and quality using validated instruments. Forty-four studies met the inclusion criteria. More consistent findings included lower oddball P3 and higher resting beta at baseline predicting negative outcomes, and abstinence-mediated longitudinal decrease in cue-elicited P3 amplitude and resting beta power. Other findings included abstinence or treatment-related changes in late positive potential (LPP) and N2 amplitudes, as well as in delta and theta power. Existing studies were heterogeneous and limited in terms of specific substances of interest, brief times for follow-ups, and inconsistent or sparse results. Encouragingly, in this limited but maturing literature, many studies demonstrated partial associations of EEG markers with abstinence, treatment outcomes, or pre-post treatment-effects. Studies were generally of good quality in terms of risk of bias. More EEG studies are warranted to better understand abstinence- or treatment-mediated neural changes or to predict SUD treatment outcomes. Future research can benefit from prospective large-sample cohorts and the use of standardized methods such as task batteries. EEG markers elucidating the temporal dynamics of changes in brain function related to abstinence and/or treatment may enable evidence-based planning for more effective and targeted treatments, potentially pre-empting relapse or minimizing negative lifespan effects of SUD.
Collapse
Affiliation(s)
- Tarik S. Bel-Bahar
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Anam A. Khan
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Riaz B. Shaik
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Muhammad A. Parvaz
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| |
Collapse
|
3
|
Bilgrami ZR, Sarac C, Srivastava A, Herrera SN, Azis M, Haas SS, Shaik RB, Parvaz MA, Mittal VA, Cecchi G, Corcoran CM. Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings. Schizophr Res 2022; 245:90-96. [PMID: 35094918 PMCID: PMC10062407 DOI: 10.1016/j.schres.2022.01.019] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2021] [Revised: 01/09/2022] [Accepted: 01/11/2022] [Indexed: 12/21/2022]
Abstract
Language deficits are prevalent in psychotic illness, including its risk states, and are related to marked impairment in functioning. It is therefore important to characterize language impairment in the psychosis spectrum in order to develop potential preventive interventions. Natural language processing (NLP) metrics of semantic coherence and syntactic complexity have been used to discriminate schizophrenia patients from healthy controls (HC) and predict psychosis onset in individuals at clinical high-risk (CHR) for psychosis. To date, no studies have yet examined the construct validity of key NLP features with respect to clinical ratings of thought disorder in a CHR cohort. Herein we test the association of key NLP metrics of coherence and complexity with ratings of positive and negative thought disorder, respectively, in 60 CHR individuals, using Andreasen's Scale of Assessment of Thought, Language and Communication (TLC) Scale to measure of positive and negative thought disorder. As hypothesized, in CHR individuals, the NLP metric of semantic coherence was significantly correlated with positive thought disorder severity and the NLP metrics of complexity (sentence length and determiner use) were correlated with negative thought disorder severity. The finding of construct validity supports the premise that NLP analytics, at least in respect to core features of reduction of coherence and complexity, are capturing clinically relevant language disturbances in risk states for psychosis. Further psychometric study is required, in respect to reliability and other forms of validity.
Collapse
Affiliation(s)
- Zarina R Bilgrami
- Icahn School of Medicine at Mount Sinai New York, NY, USA; Department of Psychology, Emory University, Atlanta, GA, USA.
| | - Cansu Sarac
- Icahn School of Medicine at Mount Sinai New York, NY, USA; Department of Psychology, Long Island University-Brooklyn, 1 University Plaza, Brooklyn, NY, USA
| | | | | | - Matilda Azis
- Department of Psychosis Studies, Kings College, London, UK
| | | | - Riaz B Shaik
- Icahn School of Medicine at Mount Sinai New York, NY, USA
| | | | - Vijay A Mittal
- Northwestern University, Department of Psychology, Evanston, IL, USA
| | | | - Cheryl M Corcoran
- Icahn School of Medicine at Mount Sinai New York, NY, USA; James J. Peters VA Medical Center Bronx, NY, USA
| |
Collapse
|
4
|
Sarac C, DeLuca JS, Bilgrami ZR, Herrera SN, Myers JJ, Dobbs MF, Haas SS, Todd TL, Srivastava A, Jespersen R, Shaik RB, Landa Y, Davidson L, Pavlo AJ, Corcoran CM. A qualitative study on identity in individuals at clinical high risk for psychosis: " … Why does it have to be one thing?". Psychiatr Rehabil J 2022; 45:44-53. [PMID: 34138610 PMCID: PMC8678395 DOI: 10.1037/prj0000492] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE Qualitative research can shed light on the subjective experiences of individuals at clinical high risk (CHR) for psychosis, complement quantitative research, broaden our understanding of experiencing CHR, and inform intervention development. The aim of this study was to explore life experiences of individuals at CHR through qualitative research. METHOD Participants were 37 individuals at CHR (20 male, 17 female) aged 16-34 (Mage = 23.32 ± 5.26), and 16 healthy controls (HCs; 7 male, 9 female) aged 18-34 (Mage = 25.37 ± 4.05). Qualitative data were obtained through open-ended interviews (30-45 min). No a priori hypotheses were made, and thematic analyses were used to develop themes. RESULTS Four major themes and one subtheme related to identity were identified through the iterative thematic analysis: defining a self-concept (with a subtheme of creativity), identity development/formation, feeling different from others, and change from a former self. Over 80% of the CHR cohort spontaneously discussed topics related to their identity, compared to 38% of HCs. HCs only reported content within the defining a self-concept theme, while the CHR group reported content within all themes. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE The present study demonstrates that identity formation is a major process for youth in general and that psychosis experiences can make this process more challenging. CHR participants spontaneously brought up multiple themes related to identity in open-ended interviews, suggesting the relevance of this topic in this population. Clinicians should continue to probe identity-related concerns on an individual basis and research should focus on integrating this framework into the conceptualization and treatment of CHR. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Collapse
|
5
|
Neppala GK, Terkuhle I, Wagner A, Lepow L, Shaik RB, Freed R, Kimhy D, Pietrzak RH, Velthorst E, Feder A, Ivanov I, Parvaz MA. Social Isolation-Mediated Exacerbation of Negative Affect in Young Drinkers during the COVID-19 Pandemic. Brain Sci 2022; 12:brainsci12020214. [PMID: 35203977 PMCID: PMC8870361 DOI: 10.3390/brainsci12020214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Revised: 01/26/2022] [Accepted: 02/02/2022] [Indexed: 02/04/2023] Open
Abstract
Emerging research on psychological adjustment during the COVID-19 outbreak has suggested that young people may be particularly vulnerable to increases in negative affect during the pandemic. However, the association between alcohol use in youth and change in negative affect during this unprecedented time is not clear. Using an online survey, this study obtained scores on negative affect (before and during the COVID-19 pandemic), pandemic-related stress, change in drinking frequency, and traits including resilience, impulsivity and anhedonia, from a sample of drinkers and non-drinkers, up to the age of 21. Young drinkers experienced a greater increase in negative affect during the pandemic compared to non-drinkers, and this differential rise in negative affect was mediated by the pandemic-related stress of social isolation. Young drinkers also experienced a decrease in alcohol use during the pandemic, but this was not associated with a change in negative affect. Interestingly, young drinkers with greater resilience and lower anhedonia reported less increase in negative affect during the COVID-19 pandemic. Taken together, these results show that the greater increase in negative affect that young drinkers experienced during the COVID-19 pandemic, compared to their non-drinking counterparts, was mediated by pandemic-related social isolation. Moreover, greater resilience and lower anhedonia may have served as protective factors for mitigating the social isolation-induced worsening of negative affect in young drinkers during the pandemic. These findings may inform future studies investigating potential indicators of maladaptive affective responses to public health crises in vulnerable adolescent populations.
Collapse
Affiliation(s)
- Gopi K. Neppala
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Isabel Terkuhle
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Ariella Wagner
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Lauren Lepow
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Riaz B. Shaik
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Rachel Freed
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - David Kimhy
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Robert H. Pietrzak
- U.S. Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, VA Connecticut Healthcare System, West Haven, CT 06516, USA;
- Department of Psychiatry, Yale School of Medicine, New Haven, CT 06511, USA
- Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT 06520, USA
| | - Eva Velthorst
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Adriana Feder
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Iliyan Ivanov
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
| | - Muhammad A. Parvaz
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; (G.K.N.); (I.T.); (A.W.); (L.L.); (R.B.S.); (R.F.); (D.K.); (E.V.); (A.F.); (I.I.)
- Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
- Correspondence:
| |
Collapse
|
6
|
Herrera SN, Sarac C, Bilgrami ZR, Dobbs MF, Jespersen R, Haas SS, Garg S, Shaik RB, Landa Y, Corcoran CM. A case report and first-person account of an individual at risk for psychosis who improved during the COVID-19 pandemic. Psychosis 2022; 14:190-199. [PMID: 36017476 PMCID: PMC9398192 DOI: 10.1080/17522439.2021.1915369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Background The COVID-19 pandemic is expected to increase stress and mental health symptoms. We present the case of a young man at risk for psychosis who has paradoxically shown symptomatic and functional improvement as a result of circumstances produced by COVID-19. These changes were unexpected given the client's persistent mental health struggles in the year leading up to the COVID-19 outbreak in the United States and the expectation of an exacerbation of psychotic-like symptoms. Methods This report is based on clinical assessments and the client's first-person account during the height of the pandemic when stay at home orders were in place. Results During the pandemic, the client demonstrated increased agency by taking on more responsibility at home and obtaining part-time employment. He showed improvement in his mood and relationships with others, had less symptom-related distress, and significantly reduced his cannabis use. The client interpreted these improvements in terms of changing his mindset toward more adaptive thoughts and engaging in healthy coping skills such as praying, reading, and healthy eating. Conclusions This case highlights the importance of fostering agency in clients during a time of crisis and ensuring that clinicians be aware of potential biases about mental health symptom exacerbation.
Collapse
Affiliation(s)
| | - Cansu Sarac
- Icahn School of Medicine at Mount Sinai, New York, NY 10029
| | | | | | | | | | - Sahil Garg
- Icahn School of Medicine at Mount Sinai, New York, NY 10029
| | - Riaz B. Shaik
- Icahn School of Medicine at Mount Sinai, New York, NY 10029
| | - Yulia Landa
- Icahn School of Medicine at Mount Sinai, New York, NY 10029
| | | |
Collapse
|
7
|
Ivanov I, Parvaz MA, Velthorst E, Shaik RB, Sandin S, Gan G, Spechler P, Albaugh MD, Chaarani B, Mackey S, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Quinlan EB, Desrivières S, Flor H, Grigis A, Gowland P, Heinz A, Ittermann B, Martinot JL, Paillère Martinot ML, Artiges E, Lemaitre H, Nees F, Orfanos DP, Paus T, Poustka L, Hohmann S, Millenet S, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Garavan H. Substance Use Initiation, Particularly Alcohol, in Drug-Naive Adolescents: Possible Predictors and Consequences From a Large Cohort Naturalistic Study. J Am Acad Child Adolesc Psychiatry 2021; 60:623-636. [PMID: 33011213 DOI: 10.1016/j.jaac.2020.08.443] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Revised: 07/14/2020] [Accepted: 09/25/2020] [Indexed: 01/25/2023]
Abstract
OBJECTIVE It is unclear whether deviations in brain and behavioral development, which may underpin elevated substance use during adolescence, are predispositions for or consequences of substance use initiation. Here, we examine behavioral and neuroimaging indices at early and mid-adolescence in drug-naive youths to identify possible predisposing factors for substance use initiation and its possible consequences. METHOD Among 304 drug-naive adolescents at baseline (age 14 years) from the IMAGEN dataset, 83 stayed drug-naive, 133 used alcohol on 1 to 9 occasions, 42 on 10 to 19 occasions, 27 on 20 to 39 occasions, and 19 on >40 occasions at follow-up (age 16 years). Baseline measures included brain activation during the Monetary Incentive Delay task. Data at both baseline and follow-up included measures of trait impulsivity and delay discounting. RESULTS From baseline to follow-up, impulsivity decreased in the 0 and 1- to 9-occasions groups (p < .004), did not change in the 10- to 19-occasions and 20- to 29-occasions groups (p > .294), and uncharacteristically increased in the >40-occasions group (p = .046). Furthermore, blunted medial orbitofrontal cortex activation during reward outcome at baseline significantly predicted higher alcohol use frequency at follow-up, above and beyond behavioral and clinical variables (p = .008). CONCLUSION These results suggest that the transition from no use to frequent drinking in early to mid-adolescence may disrupt normative developmental changes in behavioral control. In addition, blunted activity of the medial orbitofrontal cortex during reward outcome may underscore a predisposition toward the development of more severe alcohol use in adolescents. This distinction is clinically important, as it informs early intervention efforts in preventing the onset of substance use disorder in adolescents.
Collapse
Affiliation(s)
| | | | | | - Riaz B Shaik
- Icahn School of Medicine at Mount Sinai, New York
| | - Sven Sandin
- Icahn School of Medicine at Mount Sinai, New York; Karolinska Institutet, Stockholm, Sweden
| | - Gabriela Gan
- Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany
| | | | | | | | | | - Tobias Banaschewski
- Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany
| | - Arun L W Bokde
- School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland
| | - Uli Bromberg
- University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | | | | | | | - Herta Flor
- Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany; University of Mannheim, Mannheim, Germany
| | | | - Penny Gowland
- University of Nottingham, University Park, Nottingham, United Kingdom
| | - Andreas Heinz
- 12Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany
| | - Bernd Ittermann
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany
| | - Jean-Luc Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000, University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France
| | - Marie-Laure Paillère Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000, University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France
| | - Eric Artiges
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000, University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France
| | - Herve Lemaitre
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000, University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France
| | - Frauke Nees
- Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany
| | | | - Tomáš Paus
- University of Toronto, Ontario, M6A 2E1, Canada
| | - Luise Poustka
- University Medical Centre Göttingen, Göttingen, Germany; and the Medical University of Vienna, Vienna, Austria
| | - Sarah Hohmann
- Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany
| | - Sabina Millenet
- Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany
| | | | | | - Henrik Walter
- 12Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany
| | - Robert Whelan
- School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland
| | | | | |
Collapse
|
8
|
Haas SS, Doucet GE, Garg S, Herrera SN, Sarac C, Bilgrami ZR, Shaik RB, Corcoran CM. Linking language features to clinical symptoms and multimodal imaging in individuals at clinical high risk for psychosis. Eur Psychiatry 2020; 63:e72. [PMID: 32778184 PMCID: PMC7443790 DOI: 10.1192/j.eurpsy.2020.73] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND Abnormalities in the semantic and syntactic organization of speech have been reported in individuals at clinical high-risk (CHR) for psychosis. The current study seeks to examine whether such abnormalities are associated with changes in brain structure and functional connectivity in CHR individuals. METHODS Automated natural language processing analysis was applied to speech samples obtained from 46 CHR and 22 healthy individuals. Brain structural and resting-state functional imaging data were also acquired from all participants. Sparse canonical correlation analysis (sCCA) was used to ascertain patterns of covariation between linguistic features, clinical symptoms, and measures of brain morphometry and functional connectivity related to the language network. RESULTS In CHR individuals, we found a significant mode of covariation between linguistic and clinical features (r = 0.73; p = 0.003), with negative symptoms and bizarre thinking covarying mostly with measures of syntactic complexity. In the entire sample, separate sCCAs identified a single mode of covariation linking linguistic features with brain morphometry (r = 0.65; p = 0.05) and resting-state network connectivity (r = 0.63; p = 0.01). In both models, semantic and syntactic features covaried with brain structural and functional connectivity measures of the language network. However, the contribution of diagnosis to both models was negligible. CONCLUSIONS Syntactic complexity appeared sensitive to prodromal symptoms in CHR individuals while the patterns of brain-language covariation seemed preserved. Further studies in larger samples are required to establish the reproducibility of these findings.
Collapse
Affiliation(s)
- S S Haas
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - G E Doucet
- Boys Town National Research Hospital, Omaha, Nebraska, USA
| | - S Garg
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - S N Herrera
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - C Sarac
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Z R Bilgrami
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - R B Shaik
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - C M Corcoran
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| |
Collapse
|
9
|
Larsen EM, Herrera S, Bilgrami ZR, Shaik RB, Crump F, Sarac C, Shen J, Yang LH, Corcoran CM. Self-stigma related feelings of shame and facial fear recognition in individuals at clinical high risk for psychosis: A brief report. Schizophr Res 2019; 208:483-485. [PMID: 30700396 PMCID: PMC6544472 DOI: 10.1016/j.schres.2019.01.027] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Revised: 01/15/2019] [Accepted: 01/18/2019] [Indexed: 10/27/2022]
Affiliation(s)
- Emmett M. Larsen
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY, 10029, USA
| | - Shaynna Herrera
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY, 10029, USA; Mental Illness Research, Education, and Clinical Center (MIRECC VISN 2), James J. Peter Veterans Affairs Medical Center, 130 West Kingsbridge Rd, Bronx, NY 10468, USA.
| | - Zarina R. Bilgrami
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY, 10029, USA
| | - Riaz B. Shaik
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY, 10029, USA
| | - Francesca Crump
- New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA
| | - Cansu Sarac
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY, 10029, USA.
| | - Jenny Shen
- City of Hope National Medical Center, Duarte, CA 91010, USA.
| | - Lawrence H. Yang
- New York University College of Public Health, 715 Broadway, New York, NY, 10003, USA,Columbia University Mailman School of Public Health, 722 West 168th Street, New York, NY 10032, USA
| | - Cheryl M. Corcoran
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY, 10029, USA,Mental Illness Research, Education, and Clinical Center (MIRECC VISN 2), James J. Peter Veterans Affairs Medical Center, 130 West Kingsbridge Rd, Bronx, NY, 10468, USA,New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA
| |
Collapse
|